Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating a PARP inhibitor with a CDK4/6 inhibitor and endocrine therapy for HR+/HER2-negative metastatic breast can…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer [Phase 4]
Phase 4 exploratory clinical study of dalpiciclib combined with aromatase inhibitor neoadjuvant therapy for stage II-III HR+/HER2- breast ca…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China [NA]
This clinical trials update notes a completed pilot study evaluating a financial navigation program aimed at reducing financial toxicity for…
-
FDA approval · 2024-09-24FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Teyro Labs Private Limited)
FDA approved a supplemental application for Gemcitabine hydrochloride from Teyro Labs Private Limited, authorizing continued approval of thi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: VR Ultrasound Guided Breast Localization [NA]
A VR ultrasound-guided breast localization trial (NCT04251507) sponsored by Prisma Health-Upstate has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib [EARLY_Phase 1]
Early-phase trial comparing fulvestrant plus palbociclib versus tamoxifen plus palbociclib in metastatic breast cancer is completed, with re…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors [Phase 2]
Phase 2 trial evaluating vaginal DHEA for vaginal atrophy and menopausal symptoms in postmenopausal breast cancer survivors on aromatase inh…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC) [Phase 1]
Pfizer's Phase 1 study of Vepdegestrant (ARV-471) for ER+/HER2- locally advanced or metastatic breast cancer has posted results; the trial i…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction
A clinical trial sponsored by National Taiwan University Hospital evaluating East Asian breast cancer genomics to predict recurrence risk, c…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer [NA]
This is an update on the EXERT-BCN study testing an exercise and nutrition program to improve body composition after breast cancer treatment…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients
ENDO-BRAIN is a clinical trial assessing the cognitive effects of aromatase inhibitor therapy in breast cancer patients; recruitment is ongo…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: CARE Initiative: Real-world Emulation of the PALOMA-2 Trial
This update reports the completion of the CARE Initiative, a real-world emulation of the PALOMA-2 trial, which evaluated palbociclib in comb…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Online Individual Intervention Program to Make Sense of People's Experiences After a Breast Cancer Diagnosis [NA]
This clinical trial update reports the completion of an online intervention program intended to help people interpret and cope with experien…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Reborn Lifestyle Adjustment Program
The Reborn Lifestyle Adjustment Program trial sponsored by Atlas University is currently recruiting for breast cancer and quality-of-life ou…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 study comparing ribociclib plus goserelin acetate with hormonal therapy versus combination chemotherapy in premenopausal or perimeno…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer [Phase 1]
This Phase 1 trial investigates changes in PD-L1 expression during preoperative therapy with nab-paclitaxel and pembrolizumab in hormone rec…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer [NA]
An exploratory neoadjuvant study is evaluating a three-drug combination of dalpiciclib, letrozole, and anlotinib for Stage II-III postmenopa…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients
This clinical trial update describes a study evaluating the efficacy and safety of ipsilateral supraclavicular lymph node dissection for pat…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine Therapy [NA]
This document provides an update on a clinical trial studying the effect of a yoga program on quality of life in women with breast cancer re…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Palbociclib in Real World Practice
This clinical trial update reports the completion of a real-world study of palbociclib in advanced/metastatic breast cancer, with results po…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer [Phase 3]
Phase 3 neoadjuvant trial comparing nab-paclitaxel–based therapy (Nab-PHP) with a taxane-based regimen (TCbHP) for HER2-positive early breas…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade
This clinical trial update describes observing exhaled volatile organic compound biomarkers in women with BI-RADS 4 breast ultrasound findin…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for QUILT-2.015 evaluating AMG 479 in combination with exemestane or fulvestrant in postmenopausal women with …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating enzalutamide plus paclitaxel in stage I-III androgen receptor-positive triple-negative breast cancer ha…